Metropolis Healthcare Share Price Live
Live Metropolis Healthcare Share Price Chart
Metropolis Healthcare Performance
Days Range
| Previous Close | ₹1,921.80 |
|---|---|
| Open | ₹1,929 |
| Volume | 5,281 |
| Day's Range | ₹1,916.00 - ₹1,943.50 |
|---|---|
| 52W Range | ₹1,315.00 - ₹2,263.00 |
| Market Cap | ₹9,942.57 Cr |
Metropolis Healthcare Fundamentals
| ROCE(TTM) | 14.12 |
|---|---|
| P/E Ratio (TTM) | 62.6 |
| P/B Ratio | 6.94 |
| Industry P/E | 60.11 |
| Debt to Equity | 0.14 |
| ROE | 11.05 |
| EPS (TTM) | 30.53 |
| Dividend Yield | 0 |
| Book Value | 276.43 |
| Face Value | 2 |
| ROCE(TTM) | 14.12 |
|---|---|
| P/E Ratio (TTM) | 62.6 |
| P/B Ratio | 6.94 |
| Industry P/E | 60.11 |
| Debt to Equity | 0.14 |
| ROE | 11.05 |
|---|---|
| EPS (TTM) | 30.53 |
| Dividend Yield | 0 |
| Book Value | 276.43 |
| Face Value | 2 |
Metropolis Healthcare Financials
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Net Sales | 322.77 | 345.29 | 386.06 | 429.19 |
| Expenses | 278.45 | 311.62 | 327.15 | 353.37 |
| Profit before tax | 42.34 | 36.04 | 61.23 | 71.03 |
| Operating Profit | 31.47 | 29.23 | 45.25 | 52.89 |
| Net Profit | 31.47 | 29.23 | 45.25 | 52.89 |
| ESP in Rs | 6.12 | 5.69 | 8.70 | 10.17 |
Metropolis Healthcare Shareholding Pattern
| Held by | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 49.43% | 49.4% | 48.9% | 48.89% | 48.89% |
| Flls | 18.56% | 16.73% | 15.29% | 12.83% | 12.52% |
| Dlls | 28.02% | 30% | 30.3% | 32.4% | 33.1% |
| Public | 3.99% | 3.87% | 5.52% | 5.88% | 5.49% |
About Metropolis Healthcare
Metropolis Healthcare Limited is one of the leading diagnostics companies in India. It owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East. The Chairman, Dr Sushil Shah, founded the company in 1981 and established the first referral laboratory. In 1992, It started clinical research services. The company continued its organic growth and finished its first major acquisition of Sudharma in Kerala in 2001. During the same year, the company started the home service vertical.
In 2013, it expanded the services of Metropolis to developing African countries. After three years, the company inducted the new professional management team and rolled out Metropolis's retail strategy in 2016. The company was listed on the Indian stock exchanges successfully in 2019 after an IPO to the public. In 2023, it launched Metropolis 3.0 strategy to broaden its consumer reach via the Direct to Consumer (D2C) model with a focus on building chronic and wellness businesses.
Business Segments
- Pathology Testing Services: Under this segment, the company provides services such as Blood Tests, Diagnostics and Wellness services. It has operations across India, Africa, South Asia, and the Middle East.
- Corporate Wellness: Under this segment, it ties up with organisations and provides pre-employment check-ups, employee health plans, and annual check-ups for corporates to build a healthy workforce.
- Lab in Hospitals: The company partners with hospitals to provide diagnostics services. Currently, it is a partnership with many hospitals across geographies and offers full-scale in-house pathology services and solutions.
- Clinical Research Services: It offers analytical and support services such as logistics and EDI to contract research organisations for their clinical research projects.
- Amin's Pathology Laboratory Private Limited: It is a wholly-owned subsidiary which provides over 50 different types of medical with the latest and the best automated equipment.
- Centralab Healthcare Services Private Limited: This is a wholly owned subsidiary which is engaged in providing healthcare services to customers.
Key Personnel:
Dr Sushil Shah, Chairman and Executive Director Dr. Sushil Shah is the Founder and Chairman of the company. He completed his M.B.B.S. in 1972 and M.D. in Pathology and Bacteriology from Grant Medical College in 1975. In 1978, he received a Research Fellowship in Endocrine Pathology at the esteemed Cornell Medical Centre. Ms Ameera Shah, Promoter and Managing Director Ms Ameera Shah is the Promoter and Managing Director of the company. She is a global thought leader in the healthcare industry and played an instrumental role in changing the pathology industry landscape in the country.Corporate Action
The company has no history of bonus issues, stock splits and other corporate actions.Parent Organisation
Indian Private
Managing Director
Ameera Sushil Shah
Founded
2000
NSE Symbol
METROPOLIS
Top Mutual Funds Invested in Metropolis Healthcare Share
Top Mutual Funds Invested in Metropolis Healthcare Share
Peer Comparison
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Max Healthcare Institute Ltd | 1,073.4 -1.30 (-0.12%) | ₹1,04,587.30 | 940.05 - 1,314.3 |
| Apollo Hospitals Enterprise Ltd | 7,097.5 6.50 (0.09%) | ₹1,01,951.23 | 6,001.0 - 8,099.5 |
| Fortis Healthcare Ltd | 861.0 -2.85 (-0.33%) | ₹65,251.03 | 577.0 - 1,104.3 |
| Narayana Hrudayalaya Ltd | 1,875.8 -13.50 (-0.71%) | ₹38,609.89 | 1,256.55 - 2,370.2 |
| Aster DM Healthcare Ltd | 632.4 9.20 (1.48%) | ₹32,348.89 | 387.1 - 732.2 |
| Global Health Ltd | 1,166.8 -3.60 (-0.31%) | ₹31,428.32 | 996.45 - 1,456.5 |
Popular stocks
Metropolis Healthcare Ltd FAQs
What is the share price of Metropolis Healthcare Ltd (METROPOLIS) shares?
Metropolis Healthcare Ltd (METROPOLIS) share price as of December 10, 2025, on NSE is Rs 1930 (NSE) and Rs 1930 (BSE) on BSE.
Can I buy Metropolis Healthcare Ltd (METROPOLIS) from Angel One?
Yes, You can buy Metropolis Healthcare Ltd (METROPOLIS) shares by opening a Demat account with Angel One.
How do I buy Metropolis Healthcare Ltd (METROPOLIS) from Angel One?
Metropolis Healthcare Ltd (METROPOLIS) share can be bought through the following modes:
1. Direct investment: You can buy Metropolis Healthcare Ltd (METROPOLIS) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Metropolis Healthcare Ltd (METROPOLIS) shares.
1. Direct investment: You can buy Metropolis Healthcare Ltd (METROPOLIS) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Metropolis Healthcare Ltd (METROPOLIS) shares.
What is the main business of Metropolis Healthcare?
The main business of Metropolis Healthcare is to provide diagnostics, blood tests, hospital laboratory solutions, and wellness services. It also partners up with research organisations to provide them with support and analytical services, including logistics and EDI, for conducting their clinical research projects.
Who are the promoters of Metropolis Healthcare?
The main promoters of Metropolis Healthcare include Metz Advisory LLP, Duru Shah Family Trust, Sushil Kanubhai Shah, Duru Sushil Shah, Sushil Shah Family Trust, and Ameera Sushil Shah.
What are the Subsidiaries that comes under Metropolis Healthcare?
Some of the subsidiaries that come under Metropolis Healthcare are Ekopath Metropolis Lab Services Private Limited, Metropolis Healthcare (Mauritius) Limited, Amin’s Pathology Laboratory Private Limited (previously known as Metropolis Wellness Products Private Limited), Metropolis Healthcare (Lanka) Private Limited, Metropolis Histoxpert Digital Services Private Limited, and Dr.Ganesan’s Hitech Diagnostic Centre Private Limited.
